Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Magenta Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-18Dec-31-17Dec-31-16
Revenues0.00.00.0
Cost of goods sold0.00.00.0
Gross profit0.00.00.0
Research and development41.327.95.8
General and administrative18.67.83.5
EBIT-60.0-35.7-9.3
Pre-tax income-57.5-35.5-9.4
Income taxes0.00.00.0
            Tax rate0.0%0.0%0.0%
Net income-57.6-35.5-9.7
 
Diluted EPS($3.13)($19.12)($65.15)
Shares outstanding (diluted)18.41.90.1
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy